Indoxyl Sulfate Induces Oxidative Changes in Plasma and Hemolysate

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2022 Jun 24

PMID 35744968

Authors

Anna Pieniazek

Michal Kopera

Lukasz Gwozdzinski

Krzysztof Gwozdzinski

Affiliations

Soon will be listed here.

Abstract

The deteriorating function of the kidneys in chronic kidney disease (CKD) is associated, among other things, with the retention of many unnecessary metabolic products in the body. Indoxyl sulfate (IS) belongs to the group of uremic toxins with a high protein binding affinity. Moreover, this compound can generate oxidative stress. We hypothesized that a high concentration of IS might induce oxidative changes in erythrocytes and plasma components, and could therefore contribute to CKD progression. In this study, we evaluated the influence of IS on the oxidative stress parameters in plasma and hemolysate. Moreover, as a result of the action of IS, we observed a decrease in the total antioxidant capacity and a change in the activity of catalase and superoxide dismutase in hemolysate and plasma. The obtained results indicate that IS induces oxidative damage to hemolysate and plasma components. Greater changes in the parameters of oxidative stress were observed in hemolysate than in plasma treated with indoxyl sulfate. The obtained results suggest that the increased concentration of IS in patients with chronic kidney disease may lead to a decrease in the lifespan of erythrocytes in their bloodstream.

Citing Articles

Suyin Detoxification Prescription Regulates the Klotho and ERK/NF-κB Signaling Pathways to Alleviate Renal Injury.

Shu L, Quan L, Wang Y, Chen Y, Yong C, Tian F Cell Biochem Biophys. 2025; .

PMID: 39966333 DOI: 10.1007/s12013-025-01695-5.

Gut microbiota regulates oxidative stress and inflammation: a double-edged sword in renal fibrosis.

Li X, Shan Q, Wu X, Miao H, Zhao Y Cell Mol Life Sci. 2024; 81(1):480.

PMID: 39636415 PMC: 11621299. DOI: 10.1007/s00018-024-05532-5.

Indoxyl sulfate induces apoptosis in mononuclear blood cells via mitochondrial pathway.

Pieniazek A, Bernasinska-Slomczewska J, Hikisz P Sci Rep. 2023; 13(1):14044.

PMID: 37640757 PMC: 10462746. DOI: 10.1038/s41598-023-40824-z.

attenuated fecal dysbiosis and metabolome changes in -administered bilateral nephrectomy mice.

Chancharoenthana W, Kamolratanakul S, Visitchanakun P, Sontidejkul S, Cheibchalard T, Somboonna N Front Immunol. 2023; 14:1131447.

PMID: 36969207 PMC: 10034098. DOI: 10.3389/fimmu.2023.1131447.

References

Pieniazek A, Brzeszczynska J, Kruszynska I, Gwozdzinski K . Investigation of albumin properties in patients with chronic renal failure. Free Radic Res. 2009; 43(10):1008-18. DOI: 10.1080/10715760903165003. View

Rizvi S, Maurya P . Alterations in antioxidant enzymes during aging in humans. Mol Biotechnol. 2007; 37(1):58-61. DOI: 10.1007/s12033-007-0048-7. View

Rysz J, Franczyk B, Lawinski J, Olszewski R, Cialkowska-Rysz A, Gluba-Brzozka A . The Impact of CKD on Uremic Toxins and Gut Microbiota. Toxins (Basel). 2021; 13(4). PMC: 8067083. DOI: 10.3390/toxins13040252. View

Dias G, Borges Bonan N, Steiner T, Tozoni S, Rodrigues S, Nakao L . Indoxyl Sulfate, a Uremic Toxin, Stimulates Reactive Oxygen Species Production and Erythrocyte Cell Death Supposedly by an Organic Anion Transporter 2 (OAT2) and NADPH Oxidase Activity-Dependent Pathways. Toxins (Basel). 2018; 10(7). PMC: 6071035. DOI: 10.3390/toxins10070280. View

Itoh Y, Ezawa A, Kikuchi K, Tsuruta Y, Niwa T . Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production. Anal Bioanal Chem. 2012; 403(7):1841-50. DOI: 10.1007/s00216-012-5929-3. View

DRABKIN D . Spectrophotometric studies; the crystallographic and optical properties of the hemoglobin of man in comparison with those of other species. J Biol Chem. 2010; 164(2):703-23. View

Lu C, Zheng C, Lu K, Liao M, Wu K, Ma M . Indoxyl-Sulfate-Induced Redox Imbalance in Chronic Kidney Disease. Antioxidants (Basel). 2021; 10(6). PMC: 8228088. DOI: 10.3390/antiox10060936. View

Ahmed M, Abed M, Voelkl J, Lang F . Triggering of suicidal erythrocyte death by uremic toxin indoxyl sulfate. BMC Nephrol. 2013; 14:244. PMC: 4228285. DOI: 10.1186/1471-2369-14-244. View

Rosner M, Reis T, Husain-Syed F, Vanholder R, Hutchison C, Stenvinkel P . Classification of Uremic Toxins and Their Role in Kidney Failure. Clin J Am Soc Nephrol. 2021; 16(12):1918-1928. PMC: 8729494. DOI: 10.2215/CJN.02660221. View

10.

Yamaguchi T, Takamura H, Matoba T, Terao J . HPLC method for evaluation of the free radical-scavenging activity of foods by using 1,1-diphenyl-2-picrylhydrazyl. Biosci Biotechnol Biochem. 1998; 62(6):1201-4. DOI: 10.1271/bbb.62.1201. View

11.

Jourde-Chiche N, Dou L, Cerini C, Dignat-George F, Vanholder R, Brunet P . Protein-bound toxins--update 2009. Semin Dial. 2009; 22(4):334-9. DOI: 10.1111/j.1525-139X.2009.00576.x. View

12.

Podkowinska A, Formanowicz D . Chronic Kidney Disease as Oxidative Stress- and Inflammatory-Mediated Cardiovascular Disease. Antioxidants (Basel). 2020; 9(8). PMC: 7463588. DOI: 10.3390/antiox9080752. View

13.

LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

14.

Lekawanvijit S, Kompa A, Wang B, Kelly D, Krum H . Cardiorenal syndrome: the emerging role of protein-bound uremic toxins. Circ Res. 2012; 111(11):1470-83. DOI: 10.1161/CIRCRESAHA.112.278457. View

15.

Pieniazek A, Gwozdzinski K . Changes in the conformational state of hemoglobin in hemodialysed patients with chronic renal failure. Oxid Med Cell Longev. 2015; 2015:783073. PMC: 4381738. DOI: 10.1155/2015/783073. View

16.

Pieniazek A, Gwozdzinski L, Hikisz P, Gwozdzinski K . Indoxyl Sulfate Generates Free Radicals, Decreases Antioxidant Defense, and Leads to Damage to Mononuclear Blood Cells. Chem Res Toxicol. 2018; 31(9):869-875. DOI: 10.1021/acs.chemrestox.8b00065. View

17.

Gwozdzinski K, Janicka M . Oxygen free radicals and red blood cell damage in acute renal failure. Biochem Soc Trans. 1995; 23(4):635S. DOI: 10.1042/bst023635s. View

18.

Ellman G . Tissue sulfhydryl groups. Arch Biochem Biophys. 1959; 82(1):70-7. DOI: 10.1016/0003-9861(59)90090-6. View

19.

Benzie I, Strain J . The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem. 1996; 239(1):70-6. DOI: 10.1006/abio.1996.0292. View

20.

Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P . Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003; 63(5):1934-43. DOI: 10.1046/j.1523-1755.2003.00924.x. View